3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
CNS
3
Genitourinary
2
Gastrointestinal
2
Other solid neoplasm
1
Myeloid
1
Lymphoid
1
Dermatologic
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
4
Unspecified Childhood Solid Tumor, Protocol Specific
2
Solid Tumor
2
Advanced Solid Tumors
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Refractory Solid Tumors in Children
1
Refractory Solid Tumors
1
Recurrence
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma
1
Melanoma
1
Medulloblastoma
1
Malignant Solid Tumors
1
Interventions
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
tazemetostat
2
Thiotepa
2
Mesna
2
Melphalan
2
Ifosfamide
2
Filgrastim
2
Carboplatin
2
Busulfan
2
sargramostim
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
Ursodeoxycholic Acid
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Rifampin
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Leukapheresis
1
Itraconazole
1
Immunologic Techniques
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Sirolimus
×
Other solid neoplasm
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled